Price Alert

Amarin Corporation (AMRN)

NASDAQ: AMRN · Real-Time Price · USD

15.31

0.28 (1.86%)

At close: Sep 05, 2025, 12:02 PM

1.86% (1D)

Bid	15.24
Market Cap	316.76M
Revenue (ttm)	193.24M
Net Income (ttm)	-103.59M
EPS (ttm)	-5
PE Ratio (ttm)	-3.06
Forward PE	-25.93
Analyst	Sell

Ask	15.33
Volume	19,129
Avg. Volume (20D)	110,958
Open	15.16
Previous Close	15.03
Day's Range	15.01 - 15.35
52-Week Range	7.00 - 17.49
Beta	0.78

About AMRN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol AMRN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Amarin Corporation is scheduled to release its earnings on Oct 29, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+27.3%

Amarin shares are trading higher after the company... Unlock content with Pro Subscription

5 months ago

-14.98%

Amarin Corporation shares are trading lower after the company announced its intent to effect a 1-for-20 ADS ratio change. The company reported Q4 financial results.

News

1 week ago · zacks.com

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Here is how Amarin (AMRN) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.

3 weeks ago · zacks.com

Amarin (AMRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Amarin (AMRN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revision...

4 weeks ago · zacks.com

Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?

Here is how Amarin (AMRN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

1 month ago · zacks.com

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises

AMRN beats second-quarter estimates for earnings. Revenues rise year over year on strong licensing gains.

1 month ago · seekingalpha.com

Amarin Corporation plc (AMRN) Q2 2025 Earnings Call Transcript

Amarin Corporation plc (NASDAQ:AMRN ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Aaron D. Berg - CEO, President & Director Mark Marmur - Corporate Participant Peter...